Paula Lago

Metabolic control of T cell immune response through glycans in inflammatory bowel disease

Ana M. Dias, Alexandra Correia, Márcia S. Pereira et al. · Proceedings of the National Academy of Sciences · 2018 · 108 citations · Full text

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

Laurent Peyrin‐Biroulet, Jessica R. Allegretti, David T. Rubin et al. · Gastroenterology · 2023 · 86 citations · Full text

Dysregulation of T cell receptor N-glycosylation: a molecular mechanism involved in ulcerative colitis

Ana M. Dias, Joana Dourado, Paula Lago et al. · Human Molecular Genetics · 2013 · 70 citations · Full text

Inflammation, Autoimmune Disease, Allergy +13

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 62 citations · Full text

Placebo-controlled Induction, Gastroenterology, Pathology +6

Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point‐of‐care quantitative test with two established <scp>ELISA</scp> assays

Joana Afonso, Susana Lopes, Raquel Gonçalves et al. · Alimentary Pharmacology & Therapeutics · 2016 · 60 citations